Predictive Oncology Inc (POAI) Stock Analysis

Predictive Oncology Inc (POAI) is a publicly traded company in the HEALTHCARE sector. It trades at $7.26. This page summarizes the public market data, fundamentals, and frequently asked questions for POAI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

• Price: $7.26

About Predictive Oncology Inc

Predictive Oncology Inc. (Ticker: POAI) is an innovative healthcare organization headquartered in Eagan, Minnesota, focused on revolutionizing cancer treatment through advanced predictive analytics and personalized medicine. Leveraging proprietary technologies and a robust database, the company aims to enhance patient outcomes by providing tailored therapeutic strategies that guide clinicians and researchers. With a strong emphasis on oncology innovation, Predictive Oncology is strategically ...

GNG Research Analysis

GNG Research scores Predictive Oncology Inc (POAI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for POAI.

Frequently Asked Questions

Does POAI pay dividends?

Predictive Oncology Inc (POAI) does not currently pay a regular dividend.